Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly for targeting respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. It demonstrates potent activity against p38 MAP kinase, helping to reduce inflammation. Its structure supports high binding affinity and selectivity, making it valuable in developing oral medications with improved efficacy and reduced side effects. Also explored in treatments for neurodegenerative and autoimmune disorders due to its central nervous system penetration and modulatory effects on inflammatory pathways.